chr17-59210377-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018149.7(SMG8):āc.326G>Cā(p.Gly109Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000193 in 1,610,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018149.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMG8 | NM_018149.7 | c.326G>C | p.Gly109Ala | missense_variant | 1/4 | ENST00000300917.10 | NP_060619.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMG8 | ENST00000300917.10 | c.326G>C | p.Gly109Ala | missense_variant | 1/4 | 1 | NM_018149.7 | ENSP00000300917.4 | ||
ENSG00000265303 | ENST00000577660.1 | c.136-4428G>C | intron_variant | 3 | ENSP00000464167.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000245 AC: 6AN: 245100Hom.: 0 AF XY: 0.0000301 AC XY: 4AN XY: 133100
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1458244Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 725388
GnomAD4 genome AF: 0.000105 AC: 16AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74302
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2024 | The c.326G>C (p.G109A) alteration is located in exon 1 (coding exon 1) of the SMG8 gene. This alteration results from a G to C substitution at nucleotide position 326, causing the glycine (G) at amino acid position 109 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at